8th German Pharm-Tox Summit

Metabolomic profiling and in silico ligand screening enable identification of novel drug transporter substrates

Drug transport/delivery and metabolism

Drug transport, metabolism and pharmacogenomics 

Oral presentation

Ion channels and membrane transporters	

Assessment of circulating metabolites reveals isobutyrate and propionate associated with lean NAFLD: consequences on steatosis prediction and lipid accumulation

Pharmacogenomics and personalized medicine	

Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.

Session 2

Poster

Disease models, drug development

Anti-hormonal therapy provokes BKCa channel-dependent K+ dynamics in human and murine breast cancer cells

Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.

Session 1

Cancer pharmacology	

Multi-dimensional omics profiling of a biobank reveals the interindividual variability of ADME gene expression in human liver

Nuclear receptors, enzymes and other targets		

Variant Specific Drug Therapy For Genetic Ion Channelopathies - Precision Medicine Par Excellence 

Symposien

Chair

Regulatory science - real world clinical pharmacological data analyses in personalized medicine

Matthias Schwab

Vorsitz

Weitere Beteiligungen